NCT03388125

Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection

Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection in the Management of Actively Bleeding Esophageal Varices

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 113 (actual)
• Sponsor: Sherief Abd-Elsalam · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Endoscopic Injection Sclerotherapy vs N-butyl-2-cyanoacrylate Injection

Detailed description

Endoscopic Injection Sclerotherapy versus N-butyl-2-cyanoacrylate Injection in the Management of Actively Bleeding Esophageal Varices

Conditions

• Bleeding Esophageal Varices

Interventions

Type	Name	Description
DRUG	Injection Sclerotherapy	5% ethanolamine oleate group
DRUG	N-butyl-2-cyanoacrylate	N-butyl-2-cyanoacrylate injection group

Timeline

• Start date: 2016-01-01
• Primary completion: 2017-08-01
• Completion: 2022-12-01
• First posted: 2018-01-02
• Last updated: 2018-04-24

Locations

1 site across 1 country: Egypt